What Researchers Did
Researchers conducted a retrospective, cross-sectional survey across multiple hospitals in Japan to describe the real-world clinical practice of high-flow nasal cannula oxygen therapy (HFNC) in adult patients.
What They Found
Data from 321 patients revealed that acute hypoxemic respiratory failure was the most common indication for HFNC (65.4%), followed by postoperative (15.9%) and post-extubation (11.2%) respiratory support. HFNC significantly improved respiratory parameters including PaO2, PaCO2, SpO2, and respiratory rate from baseline, with two-thirds of patients surviving to be discharged or transferred.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a descriptive cross-sectional survey, this study documents current practices and observed effects but does not establish the efficacy or safety of HFNC through controlled comparison.